In patients with AMI despite documented prior statin exposure, the prognostic associations of residual inflammatory and Lp(a) risk appeared to differ across admission LDL-C strata, supporting the potential value of LDL-C–stratified residual risk assessment.
Abstract
Patients can experience acute myocardial infarction (AMI) despite documented prior statin exposure, indicating persistent residual cardiovascular risk. The prognostic relevance of lipoprotein(a) [Lp(a)] and residual inflammation in this setting remains unclear.
This retrospective multicentre cohort study included 6,498 adults hospitalized for AMI with prior statin use. Baseline low-density lipoprotein cholesterol (LDL-C) at admission was used to stratify patients into low (< 2.6 mmol/L) and high (≥ 2.6 mmol/L) LDL-C groups. Residual risk profiles were defined by elevated Lp(a) (> 30 mg/dL), elevated high-sensitivity C-reactive protein (hs-CRP > 3 mg/L), or both. The primary outcomes were major adverse cardiovascular events (MACE) and all-cause death.
Baseline characteristics differed across residual LDL-C strata and risk profiles. During a median follow-up of 5.71 years (IQR 4.38–7.27), restricted cubic spline analyses showed a significant association between Lp(a) and outcomes only in the low LDL-C group, whereby high residual inflammatory risk (adjusted hazard ratio [aHR] 1.53, 95% CI 1.24–1.88), high residual Lp(a) risk (aHR 1.44, 95% CI 1.11–1.87), and combined residual risk (aHR 1.47, 95% CI 1.16–1.86) were each associated with higher MACE risk. In the high LDL-C group, no significant residual risk category was associated with MACE. Irrespective of LDL-C status, residual inflammatory risk alone and combined residual risk were associated with increased risks of all-cause mortality and cardiovascular death. Sensitivity analyses suggested that a 30 mg/dL Lp(a) cut-off may be more informative in this cohort.
In patients with AMI despite documented prior statin exposure, the prognostic associations of residual inflammatory and Lp(a) risk appeared to differ across admission LDL-C strata, supporting the potential value of LDL-C–stratified residual risk assessment.
Elevated RC, rather than isolated high LDL-C, is associated with adverse outcomes, which may help identify patients with residual lipid-related risk, which may help identify patients with residual lipid-related risk in STEMI patients after primary PCI.
Qian-Ying Xie, Chao-Yi Wang, Wen-Jing Zhao et al.· Frontiers in Cardiovascular...· 0 citations
Achievement of LDL-C <55 mg/dL within 6 months after AMI is independently associated with a meaningful reduction in recurrent ASCVD events in real-world practice, and the temporal mismatch between early post-discharge risk and delayed lipid assessment underscores the need for proactive, multidisciplinary care models to...
Henry C. Okoroike, Wei-Li Zheng, Faisal Hasan et al.· American Journal of Cardiolo...· 0 citations
Although eCLE does not improve discrimination beyond age and LDL-C entered separately, it is a simple and practical metric that may be useful for risk stratification of cardiovascular events after ACS.
Naoki Serikawa, M. Yoshikawa, Hiroyuki Arashi et al.· International Journal of Car...· 0 citations
In a contemporary AMI cohort, combined LLT remained low at presentation and discharge despite suboptimal LDL-C, underscoring actionable gaps in ASCVD management.
Mohammed Essa, Qifan Wu, Yuan Lu et al.· JACC: Advances· 1 citation
In secondary prevention after PCI, AUC-derived cumulative LDL-C exposure was associated with MACCE beyond available baseline clinical characteristics and may complement snapshot LDL-C assessment.
Shigetaka Kageyama, H. Sugiyama, K. Murata et al.· Atherosclerosis· 1 citation
High LDL-C levels were associated with increased cardiovascular risk in patients with chronic kidney disease but not in patients with end-stage kidney disease after multivariable adjustment, suggesting stage-specific LDL-C targets are needed to optimize cardiovascular risk management in chronic kidney disease.
N. Heo, Kyungdo Han, Kyu-Na Lee et al.· American Journal of Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.